Loading company…
Riskpilot
← Back to search
Sign in
Get full access
FRYDENDAL APOTEK AS
AS
Active
Org 926577522
Krags Gate 124, 4950 Risør
Retail sale of pharmaceutical products · NACE 4773
Est. 2021
14 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 24,6M
+18% vs 2023
EBITDA margin
3.8%
+106% vs 2023
Equity ratio
2.8%
Financial strength
Net profit 2024
NOK 591K
+182% vs 2023
EBITDA — year on year
NOK millions
1M
1M
0M
-1M
-1M
0M
2021
-1M
-100%
2022
0M
+100%
2023
1M
+100%
2024
Key figures
Annual report 2024
Revenue
NOK 24,6M
+18%
EBITDA
NOK 943K
+106%
Net profit
NOK 591K
+182%
Total assets
NOK 4,3M
-24%
Equity
NOK 122K
+126%
Employees
14
—
Company information
Legal name
FRYDENDAL APOTEK AS
Org number
926577522
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
17. mars 2021
Share capital
NOK 30 000
Employees
14 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Apotek og farmasøytiske varer, butikkhandel.
Contact
Address
Krags Gate 124, 4950 Risør
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Retail sale of pharmaceutical products
Companies in Risør
All Norway companies
Revenue
NOK millions
0M
7M
14M
22M
29M
7M
2021
15M
2022
21M
2023
25M
2024
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2021
-1M
2022
0M
2023
1M
2024
Income statement
NOK thousands
Item
2021
2022
2023
2024
Revenue
7 061
14 712
20 844
24 638
Staff expenses
−1 523
−3 542
−3 523
−3 685
EBITDA
51
−631
458
943
Depreciation & amort.
−96
−152
−134
−137
EBIT
−45
−783
324
806
Net financials
−29
−45
−55
−48
Profit before tax
−74
−828
269
758
Tax
−18
−182
59
167
Net profit
−57
−646
209
591
Balance sheet
NOK thousands
Item
2021
2022
2023
2024
Total assets
4 418
5 519
5 686
4 329
Equity
−32
−679
−469
122
Long-term debt
928
783
639
520
Short-term debt
3 523
5 414
5 517
3 687
Total debt
4 451
6 197
6 155
4 207
Financial ratios
5-year trend
EBITDA margin
3.8%
This company
15.8%
Market median
-76% vs market
2021
2024
Equity ratio
2.8%
This company
38.2%
Market median
-93% vs market
2021
2024
Return on equity
484.2%
This company
18.4%
Market median
+2532% vs market
2021
2024
Net profit margin
2.4%
This company
8.1%
Market median
-70% vs market
2021
2024
Asset turnover
5.69×
This company
1.12×
Market median
+408% vs market
2021
2024
Debt / equity
34.46×
This company
0.62×
Market median
-5458% vs market
2021
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-14 – 2021-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
BG
Bjørn Gustavsen Krabbesund
Chairman
2021
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Unknown
Individual
60%
60%
2022
Krabbesund As
Company
40%
40%
2022
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Krabbesund As
FRYDENDAL APOTEK AS
(this company)
Board network connections
Board members of FRYDENDAL APOTEK AS also hold positions in
0
other companies.
Person
Role here
Other companies
Bjørn Gustavsen Krabbesund
Chairman
0 companies